Insider · CIK 0002131341
Opipari Anthony W.
Reports to the SEC for 1 company · BOSTON, MA
Transactions
10
Companies
1
Filings
1
CIK
0002131341
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-11 | ODTXOdyssey Therapeutics, Inc.C Conversion | — |
| 2026-05-11 | ODTXOdyssey Therapeutics, Inc.M Exercise/Conversion | — |
| 2026-05-11 | ODTXOdyssey Therapeutics, Inc.F Tax Payment | −$72 |
| 2026-05-11 | ODTXOdyssey Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion | — |
| 2026-05-11 | ODTXOdyssey Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2026-05-11 | ODTXOdyssey Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion | — |
| 2026-05-11 | ODTXOdyssey Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion | — |
| 2026-05-11 | ODTXOdyssey Therapeutics, Inc. · Series D Warrants (Right to Buy)M Exercise/Conversion | — |
| 2026-05-07 | ODTXOdyssey Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-05-07 | ODTXOdyssey Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Opipari Anthony W.0001193125-26-217584SEC(opens sec.gov)
Companies
Address
C/O ODYSSEY THERAPEUTICS, INC. 51 SLEEPER STREET, SUITE 800
BOSTON, MA, 02210